ROLANDO, Barbara

ROLANDO, Barbara  

SCIENZA E TECNOLOGIA DEL FARMACO  

Mostra records
Risultati 1 - 20 di 31 (tempo di esecuzione: 0.029 secondi).
Titolo Data di pubblicazione Autore(i) File
A new generation of AKR1C3 inhibitors on the horizon: the 3- hydroxybenzazole approach to target prostate cancer 2023 Chiara Vigato, Agnese Chiara Pippione, Stefano Sainas, Iole Mannella, Laura Bertarini, Sandra Kovachka, Barbara Rolando, Osman Asghar Mirza, Karla Frydenvang, Francesca Spyrakis, Simonetta Oliaro-Bosso, Marco Lucio Lolli, Donatella Boschi
Carnosine analogues containing Phenol substructures 2012 Giorgis M.; Bertinaria M.; Rolando B.; Montanaro G.; Fruttero R.; Gasco A.
Design and synthesis of SWIR emitters for optical imaging 2022 Federica Blua, Mariangela Boccalon, Barbara Rolando, Roberta Napolitano, Massimo Bertinaria
Different multitarget approaches to manage coxibs associatedcardiovascular risk. Design and synthesis of new lumiracoxibderivatives 2012 M. Bertinaria; M. A. A. G. Shaikh; C. Cena; B. Rolando; L. Lazzarato; R. Fruttero; A. Gasco; G. E. Rovati; C. Buccellati; V. Capra; A. Sala
EFFICIENTLY TARGETING DRUG EFFLUX THROUGH MODULATION OF P-GLYCOPROTEIN ACTIVITY BY SMALL MOLECULES: DESIGN, BIOLOGICAL AND COMPUTATIONAL STUDY. 2019 Stefano Guglielmo, Marialessandra Contino, Chiara Riganti, Barbara Rolando, Loretta Lazzarato
Evaluation of the targeting ability of folate containing liposomal nitrooxy-doxorubicin. 2015 Pedrini, I.; Costamagna, F.; Buondonno, I.; Salaroglio, I. C.; Rolando, B.; Chegaev, K.; Fruttero, R.; Riganti, C.; Arpicco, S.
HYDROXYLATED HETEROCYCLES AS BIOISOSTERES OF THE CARBOXYLIC FUNCTION: DESIGN OF NEW AKR1C3 INHIBITORS ACTIVE IN PROSTATE CANCER 2023 Agnese C. Pippione, Stefano Sainas, Chiara Vigato, Iole Mannella, Irene Castellino, Sandra Kovachka, Mariia Iakovleva, Barbara Rolando, Tomasz Wrobel, Osman A. Mirza, Karla Frydenvang, Francesca Spyrakis, Simonetta Oliaro-Bosso, Marco L. Lolli, Donatella Boschi
Identification of 2,3-diaminophenazine and o-benzoquinone dioxime as the major in vitro metabolites of benzofuroxan 2003 GROSA G; B. ROLANDO; MARABELLO D; GERVASIO G
INCAPSULATED NO-GEMCITABINE: GASEOUS SOLUTION FOR MDR PANCREATIC CANCER 2019 Chegaev, K.; Masetto, F.; Gazzano, E.; Mullappily, N.; Rolando, B.; Donadelli, M.; Arpicco, S.; Riganti, C.; Fruttero, R.
MODIFIED DOXORUBICINS: "GASEOUS APPROACH" TO OVERCOME CARDIOTOXICITY AND MULTIDRUG RESISTANCE 2016 Chegaev, K.; Rolando, B.; Gazzano, E.; Riganti, C.; Fruttero, R.
Multiple-targeting ligands for AKR1C3 enzyme and androgen receptor to target prostate cancer 2021 Agnese Chiara Pippione, Zuhal Kilic-Kurt, Stefano Sainas, Iole Mannella, Barbara Rolando, Sandra Kovachka, Francesca Spyrakis, Annamaria Buschini, Serena Montalbano, Simonetta Oliaro Bosso, Marco Lolli, Donatella Boschi
Multitarget antioxidant NO-donor organic nitrates: a novel approach to overcome nitrates tolerance 2022 Elisabetta Marini, Marta Giorgis, Barbara Rolando, Konstantin Chegaev
Multitarget drugs: NO-donor doxorubicins 2012 Chegaev K.; Riganti C.; Rolando B.; Federico A.; Fruttero R.; Gasco A.
Multitarget Drugs: No-Donor Doxorubicins 2015 Chegaev, Konstantin; Riganti, Chiara; Gazzano, Elena; Rolando, Barbara; Fruttero, Roberta; Gasco, Alberto
NEW AKR1C3 INHIBITORS WITH BENZOISOXAZOLE CORE: DESIGN, SYNTHESIS AND BIOLOGICAL ACTIVITY TO TARGET PROSTATE CANCER 2022 Pippione Agnese Chiara , Iakovleva, M.; Vottero, C.; Sainas, S; Kilic-Kurt, Z.; Rolando, B; Kovachka, S; Spyrakis, F; Buschini, A.; Montalbano, S.; Oliaro Bosso, S.; Lolli, M.L, Boschi, D.
New class of NO-donor soluble aspirins 2012 Marini E.; Rolando B.; Lazzarato L.; Joseph S.; Fruttero R.
New Hydroxybenzoazole Inhibitors of Aldo-Keto Reductase 1C3 (AKR1C3): Disclosure of SAR Investigation to Target Prostate Cancer 2022 Chiara Vigato, Agnese Chiara Pippione, Iole Mannella, Mariia Iakovleva, Stefano Sainas, Simonetta Oliaro Bosso, Barbara Rolando, Sandra Kovachka, Francesca Spyrakis, Marco Lucio Lolli, Donatella Boschi
New inhibitors of Aldo-Keto Reductase 1C3 (AKR1C3) based on benzoisoxazole scaffold and their potential application in cancer 2021 Mannella, Iole, Vigato, Chiara, Pasha, Rabia; Pippione Agnese Chiara, Sainas, Stefano, Oliaro Bosso Simonetta; Rolando, Barbara; Kovachka, Sandra, Spyrakis, Francesca; Boschi, Donatella, Lolli. Marco Lucio
NITRIC OXIDE DONOR DOXORUBICINS: A USEFUL STRATEGY TO ADDRESS THE PROBLEM OF MDR IN CANCER THERAPY 2012 Rolando B.; Riganti C.; Chegaev K.; Fruttero R.; Gasco A.
Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance. 2013 Joanna Kopecka; Chiara Riganti; Barbara Rolando; Ivana Campia; Konstantin Chegaev; Loretta Lazzarato; Antonella Federico; Roberta Fruttero; Dario Ghigo